
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
| Open | 9,032.00 |
| High | 9,054.00 |
| Low | 8,955.00 |
| Prev Close | 9,030.50 |
| Volume | 10,869 |
| VWAP(₹) | 9,011.31 |
| PE Ratio(x) | 34.20 |
| EPS - TTM(₹) | 263.86 |
| MCap(₹ Cr.) | 29,294.19 |
| MCap Rank | 12 |
| PB Ratio(x) | 38.90 |
| Div Yield(%) | 0.66 |
| Face Value(₹) | 10.00 |
| 52W High(₹) | 14,540.00 |
| 52W Low(₹) | 8,955.00 |
| MCap/Sales | 7.06 |
| Beta(1 Month) | 0.32 |
| BV/Share(₹) | 232.12 |
Zero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 27.0% outperformed its 3 year CAGR of 3.03%. (Source: Standalone Financials)Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 5.01% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)P&G Share Price Update
Procter & Gamble Hygiene & Healthcare Ltd. share price moved down by -0.07% from its previous close of Rs 9,030.50. Procter & Gamble Hygiene & Healthcare Ltd. stock last traded price is 9,024.50
| Share Price | Value |
|---|---|
| Today/Current/Last | 9,024.50 |
| Previous Day | 9,030.50 |
Found Insights useful?
| 1 Day | -0.07% |
| 1 Month | -8.9% |
| 3 Months | -16.74% |
| 1 Year | -32.73% |
| 3 Years | -34.84% |
| 5 Years | -31.06% |
4 Analysts
| Ratings | Current | 1W Ago | 1M Ago | 3M Ago |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 |
| Sell | - | - | - | - |
| Strong Sell | - | - | - | - |
| # Analysts | 4 | 4 | 4 | 4 |
| Mar 2026 | Dec 2025 | Dec 2025 | Sep 2025 | Jun 2025 | |
|---|---|---|---|---|---|
| Total Income | 953.79 | 1,274.31 | 1,274.31 | 1,160.07 | 944.72 |
| Total Income Growth (%) | -25.15 | 9.85 | 0.00 | 22.80 | -6.53 |
| Total Expenses | 732.57 | 869.60 | 869.60 | 874.69 | 679.95 |
| Total Expenses Growth (%) | -15.76 | -0.58 | 0.00 | 28.64 | -14.18 |
| EBIT | 221.22 | 404.71 | 404.71 | 285.38 | 264.77 |
| EBIT Growth (%) | -45.34 | 41.81 | 0.00 | 7.78 | 21.22 |
| Profit after Tax (PAT) | 153.13 | 301.46 | 301.45 | 209.86 | 192.06 |
| PAT Growth (%) | -49.20 | 43.65 | 0.00 | 9.27 | 23.04 |
| EBIT Margin (%) | 23.19 | 31.76 | 31.76 | 24.60 | 28.03 |
| Net Profit Margin (%) | 16.05 | 23.66 | 23.66 | 18.09 | 20.33 |
| Basic EPS (₹) | 47.17 | 92.87 | 92.87 | 64.65 | 59.17 |
All figures in Rs Cr, unless mentioned otherwise
Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 27.0% outperformed its 3 year CAGR of 3.03%. (Source: Standalone Financials)Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 5.01% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)| Annual | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Total Assets | 1,803.54 | 1,754.73 | 1,858.56 | 2,137.32 | 1,681.24 |
| Total Assets Growth (%) | 2.78 | -5.59 | -13.04 | 27.13 | 2.97 |
| Total Liabilities | 1,050.07 | 1,017.74 | 1,083.70 | 1,191.29 | 943.67 |
| Total Liabilities Growth (%) | 3.18 | -6.09 | -9.03 | 26.24 | 2.75 |
| Total Equity | 753.47 | 736.99 | 774.86 | 946.03 | 737.57 |
| Total Equity Growth (%) | 2.24 | -4.89 | -18.09 | 28.26 | 3.26 |
| Current Ratio (x) | 1.22 | 1.23 | 1.22 | 1.38 | 1.32 |
| Total Debt to Equity (x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Contingent Liabilities | 0.00 | 787.79 | 609.07 | 358.75 | 334.99 |
All figures in Rs Cr, unless mentioned otherwise
Zero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)| Annual | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Net Cash flow from Operating Activities | 924.08 | 593.21 | 470.53 | 825.77 | 573.10 |
| Net Cash used in Investing Activities | 11.37 | -34.28 | 1.06 | -9.91 | -26.85 |
| Net Cash flow from Financing Activities | -844.80 | -666.23 | -861.75 | -477.01 | -568.94 |
| Net Cash Flow | 90.65 | -107.30 | -390.16 | 338.85 | -22.69 |
| Closing Cash & Cash Equivalent | 557.02 | 466.37 | 573.67 | 963.83 | 624.98 |
| Closing Cash & Cash Equivalent Growth (%) | 19.44 | -18.70 | -40.48 | 54.22 | -3.50 |
| Total Debt/ CFO (x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
All figures in Rs Cr, unless mentioned otherwise
| Annual | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Return on Equity (%) | 113.67 | 86.37 | 87.11 | 71.68 | 78.06 |
| Return on Capital Employed (%) | 135.44 | 102.66 | 110.03 | 80.85 | 97.31 |
| Return on Assets (%) | 47.48 | 36.27 | 36.31 | 31.72 | 34.24 |
| Interest Coverage Ratio (x) | 128.41 | 63.52 | 38.18 | 79.90 | 76.34 |
| Asset Turnover Ratio (x) | 2.41 | 1.87 | 2.11 | 2.05 | 2.35 |
| Price to Earnings (x) | 35.46 | 69.44 | 80.00 | 68.49 | 75.76 |
| Price to Book (x) | 40.17 | 59.92 | 69.63 | 49.08 | 58.99 |
| EV/EBITDA (x) | 24.48 | 48.08 | 52.19 | 49.99 | 50.19 |
| EBITDA Margin (%) | 28.28 | 26.92 | 24.31 | 23.20 | 21.89 |
ROE Outperforming 5 Year Average
Company delivered ROE of 113.67% in year ending Mar 31, 2026 outperforming its 5 year avg. of 86.66%. (Source: Standalone Financials)Found Financials useful?
No Data Available
Global Meltdown1st Jan 2008 to 10th Nov 2008
Covid Crisis1st Feb 2020 to 31st Mar 2020
| R1 | 9067.33 | Pivot 9011.17 | S1 | 8968.33 |
| R2 | 9110.17 | S2 | 8912.17 | |
| R3 | 9209.17 | S3 | 8813.17 |
| 5 Days | 14 Days | 28 Days |
| 202.70 | 234.61 | 246.64 |
Choose from Peers
Choose from Stocks
Found Peer Comparison useful?
MF Ownership as on 30 April 2026
913.18
Amount Invested (in Cr.)
1.98%
% of AUM
0.00
% Change (MoM basis)
539.84
Amount Invested (in Cr.)
0.713604%
% of AUM
0.00
% Change (MoM basis)
436.30
Amount Invested (in Cr.)
0.52%
% of AUM
0.00
% Change (MoM basis)
Final
600%
May 29, 2026
Board Meeting
Audited Results & Final Dividend
Mar 27, 2026
Special
250%
Jan 31, 2026
| Announced on | Meeting on |
| Mar 27, 2026 | May 28, 2026 |
| Audited Results & Final Dividend | |
| Jan 21, 2026 | Jan 30, 2026 |
| Quarterly Results & Interim Dividend | |
| Sep 29, 2025 | Nov 06, 2025 |
| Quarterly Results | |
| Jun 27, 2025 | Jul 30, 2025 |
| Quarterly Results | |
| Mar 26, 2025 | May 27, 2025 |
| Audited Results & Final Dividend | |
| Announced on | Ex-Date | Dividend% |
| Jan 31, 2026 | Feb 05, 2026 | 250% |
| Jan 30, 2026 | Feb 05, 2026 | 1700% |
| May 27, 2025 | Aug 28, 2025 | 650% |
| Jan 31, 2025 | Feb 20, 2025 | 1100% |
| May 29, 2026 | - | 600% |
| Announced on | Ex-Date |
| Sep 08, 2003 | Dec 10, 2003 |
| Bonus Ratio: 1 share(s) for every 2 shares held | |
| Sep 24, 1997 | Nov 19, 1997 |
| Bonus Ratio: 1 share(s) for every 2 shares held | |
| Aug 22, 1989 | - |
| Bonus Ratio: 4 share(s) for every 5 shares held | |
| Aug 22, 1985 | - |
| Bonus Ratio: 1 share(s) for every 2 shares held | |
| Aug 22, 1981 | - |
| Bonus Ratio: 1 share(s) for every 5 shares held | |
No Data Available
| Announced on | Ex-Date |
| Mar 30, 1991 | Jun 14, 1991 |
| Rights ratio: 1 share for every 10 held at a price of Rs 65.0 | |
| Announced on | Meeting on |
| May 28, 2025 | Aug 26, 2025 |
| - | |
| May 28, 2025 | Sep 04, 2025 |
| (Revised) | |
| Aug 30, 2024 | Nov 26, 2024 |
| (Revised) | |
| Aug 30, 2024 | Nov 25, 2024 |
| Rs.95.0000 per share(950%)Final Dividend & A.G.M. | |
| Jun 03, 2024 | Jul 05, 2024 |
| - | |
Procter & Gamble Hygiene & Healthcare Ltd., incorporated in the year 1964, is a Large Cap company (having a market cap of Rs 29,294.19 Crore) operating in FMCG sector.
Industry
Key Indices Listed On
Nifty 500, BSE 500, Nifty MNC, BSE MidCap, BSE 200
Address
P & G Plaza,Cardinal Gracias Road,Mumbai, Maharashtra - 400099
Chittranjan Dua
Chairman & Ind.DirectorKumar Venkatasubramanian
Managing DirectorGhanashyam Hegde
Executive DirectorGagan Sawhney
Non Executive DirectorDATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.